News|Podcasts|July 12, 2024

From Pathogen to Infectious Disease Diagnosis

Here is our inaugural podcast with our host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who interviews guests on connecting lab professionals to clinicians and the intricacies of assays, the next generation of diagnostics, and the nuances of interpreting test results.

Silos. This is what medical professionals often work in and they are not frequently presented with the opportunity to work across the medical aisle and collaborate with colleagues working in different specialties. Take for example, laboratory professionals and infectious disease clinicians. The former is securing test results and sending them along to clinicians, and then separately, the providers are reviewing results, interpreting them, and deciphering treatment.

What if you could break down these particular silos and make the connection between the lab and clinicians stronger and enable them to collaborate? With this idea in mind, we have launched our podcast, From Pathogen to Infectious Disease Diagnosis, which takes a deeper look at how the 2 silos can collaborate and come together. We will be doing this with the help of our esteemed podcast host, Rodney E. Rohde, PhD, SV/SM/MB(ASCP)CM, FACSc, who is a University Distinguished and Regents’ professor and chair for the Medical Laboratory Science (MLS) Program in the College of Health Professions (CHP) at Texas State University.

Today’s guest is Michael Laposata, MD, PhD, who is the professor and chair of the Department of Pathology at the University of Texas Medical Branch-Galveston. Laposata developed the concept of the Diagnostic Management Team (DMT), which brings lab professionals out of the lab and looks to aid clinicians with interpretation of testing results.1 Additionally, his school, the University of Texas Medical Branch-Galveston, was one of the first universities in the United States that developed a Doctorate of Clinical Laboratory Studies (DCLS) program around the DMT concept.

“The Doctorate of Clinical Laboratory Sciences (DCLS) is an advanced professional doctorate designed for practicing clinical laboratory scientists who wish to further their level of clinical expertise and to develop leadership and management skills. The purpose of the program is the development of clinical laboratory sciences graduates who function as practitioners, community leaders, educators, and scholars in the profession of clinical laboratory science and the discipline of clinical laboratory science,” According to UTMB’s website.2

Today’s episode is the first of a 2-part episode on the DMT novel concept and this evolving field. Sit back and enjoy this first episode. And if you have any ideas for future podcasts or feedback, please email John Parkinson at [email protected].



Reference
1. Using Laboratory Medicine to Support Direct Patient Care. American Society of Microbiology. October 4, 2021. Accessed July 12, 2024.
https://asm.org/articles/2021/october/using-laboratory-medicine-to-support-direct-patien
2. Clinical Laboratory Sciences. UTMB. Updated May 13, 2024. Accessed July 12, 2024.
https://shp.utmb.edu/clls/dcls/home

Related to this article

Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.